B. Bouzahzah et al., GROWTH-CONTROL AND GENE-EXPRESSION IN A NEW HEPATOCELLULAR-CARCINOMA CELL-LINE, HEP40 - INHIBITORY ACTIONS OF VITAMIN-K, Journal of cellular physiology, 165(3), 1995, pp. 459-467
The growth characteristics of a newly established cell line, Hep40, de
rived from a human hepatoma are described. An absolute requirement was
found for serum to mediate cell growth. Neither EGF, TGF-alpha, nor H
GF altered cell growth in the presence or absence of serum. A partial
suppression of cell growth was achieved by several TGF-beta family pro
teins. Affinity crosslinking gels using I-125-labeled TGF-beta showed
a significant decrease in the TGF-beta cell-surface type II receptor i
n Hep40 cells, compared to the TGF-beta-sensitive Hep3B cell line. How
ever, growth could be completely suppressed by addition of vitamins K
to the culture medium in both Hep40 and several other hepatoma cell li
nes. Growth suppression by vitamins K was accompanied by an increased
level of transcripts for c-myc, c-jun, and prothrombin genes, in contr
ast to the actions of TGF-beta 1 protein, which caused a decrease in t
he level of c-myc transcripts. These data show that this new human hep
atoma cell line has partial resistance to growth inhibition by TGF-bet
a with a unique TGF-beta receptor defect. However, growth was complete
ly suppressed by vitamins K. The differing gene expression patterns in
response to TGF-beta as compared to vitamin K suggest that these two
growth inhibitors act through differing pathways. (C) 1995 Wiley-Liss,
Inc.